← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1998Last known activity
Jun 30, 2026
Timeline
1990s
- Jan 1, 1991
National Center for Complementary and Integrative Health (NCCIH)— Founded
Drugs by trial phase (212 distinct, 263 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (35 own, 0 via acquisition)
Phase 2 (88 own, 0 via acquisition)
Phase 1 (50 own, 0 via acquisition)
Other trials (24 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute-Phase Reaction
- Adenocarcinoma
- Adenocarcinoma of Lung
- Alcoholism
- Alzheimer Disease
- Amnesia
- Amyotrophic Lateral Sclerosis
- Anemia, Sickle Cell
- Anovulation
- Anxiety Disorders
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Atherosclerosis
- Attention Deficit Disorder with Hyperactivity
- Back Pain
- Bacteriuria
- Bipolar Disorder
- Body Weight
- Bone Diseases, Metabolic
- Brain Diseases
- Breast Neoplasms
- Cachexia
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Carotid Artery Diseases
- Carpal Tunnel Syndrome
- Cataract
- Celiac Disease
- Cleft Lip
- Cleft Palate
- Cognitive Dysfunction
- Common Cold
- Communicable Diseases
- Compulsive Personality Disorder
- Coronary Artery Disease
- Crohn Disease
- Cumulative Trauma Disorders
- Dementia
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Neuropathies
- Diarrhea
- Disease
- Down Syndrome
- Dyslipidemias
- Eclampsia
- Endometriosis
- Epilepsies, Partial
- Epilepsy
- Eye Diseases
- Fatigue
- Fatty Liver
- Food Hypersensitivity
- Glucose Intolerance
- Heart Diseases
- Heart Failure
- HELLP Syndrome
- Hepatic Encephalopathy
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- HIV Infections
- Hot Flashes
- Huntington Disease
- Hyperandrogenism
- Hypercholesterolemia
- Hyperglycemia
- Hyperkinesis
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Hypersensitivity
- Hypertension
- Hypertriglyceridemia
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Inflammation
- Inflammatory Bowel Diseases
- Influenza, Human
- Insulin Resistance
- Intermittent Claudication
- Kidney Calculi
- Kidney Diseases
- Kidney Failure, Chronic
- Liver Diseases
- Low Back Pain
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphedema
- Macular Degeneration
Recent trials (50)
- NCT07306364CollaboratorPhase 2Jun 30, 2026
- NCT07189585CollaboratorPhase 2Apr 1, 2026
- NCT07281352CollaboratorPhase 1/Phase 2Jan 5, 2026
- NCT07078344CollaboratorPhase 1Jul 31, 2025
- NCT06898788CollaboratorEarly Phase 1May 15, 2025
- NCT06808230CollaboratorN/AApr 30, 2025
- NCT06692933CollaboratorEarly Phase 1Jun 20, 2024
- NCT06355414CollaboratorPhase 1Apr 22, 2024
- NCT05814055CollaboratorPhase 2Feb 29, 2024
- NCT06003270CollaboratorPhase 2Sep 30, 2023
- NCT05876858CollaboratorEarly Phase 1Jun 13, 2023
- NCT05846451CollaboratorEarly Phase 1Jun 1, 2023
- NCT05571592CollaboratorPhase 2Dec 14, 2022
- NCT05619289CollaboratorPhase 2Nov 30, 2022
- NCT05519683CollaboratorPhase 2/Phase 3Nov 2, 2022
Details
- Founded
- Bethesda, MD, US Jan 1, 1991
- Last known activity
- Jun 30, 2026